Methanex Sells New Zealand Gas Entitlements to Focus on Core Assets

What happened

Methanex has agreed to sell substantially all of its New Zealand natural gas contractual entitlements starting in Q1 2027 through their expiration at decade-end. The move rationalizes the company's portfolio as it concentrates on North American production and integrates the OCI acquisition. While financial terms were not disclosed, the sale likely reflects diminished strategic value in New Zealand gas given declining fields and higher-return opportunities elsewhere. The decision follows the indefinite idling of Trinidad's Titan plant earlier this year, underscoring management's willingness to exit uncompetitive feedstock positions. For investors, this is a small step toward simplifying the asset base and potentially generating cash for debt reduction, but it removes a long-dated optionality that might have become valuable if gas markets tightened.

Implication

Investors should view this as management continuing to prioritize balance-sheet repair and high-grading the portfolio rather than chasing marginal production. The sale likely provides a modest cash infusion or eliminates future capital commitments associated with New Zealand operations, aligning with the company's stated deleveraging framework. However, it also closes the door on any potential upside from New Zealand methanol production should regional gas economics improve, though that was never a central pillar of the bull case. The core thesis remains unchanged: Methanex's near-term fate hinges on whether elevated methanol prices in Q2 translate into durable free cash flow amid normalization risks and OCI integration execution. Accordingly, the WAIT rating and $47 attractive entry / $62 trim levels from the master report remain valid, with no need to adjust based on this development.

Thesis delta

The sale of New Zealand gas entitlements does not alter the fundamental thesis, which is centered on methanol pricing trends, Trinidad idling, and OCI integration. It slightly reduces geographic diversification and removes a source of potential future capacity, but given New Zealand's diminishing role, the impact on valuation is negligible. Management's action reinforces the deleveraging-first approach, but we await evidence of cash conversion in Q2 results before changing our stance.